首页 | 本学科首页   官方微博 | 高级检索  
     

匹伐他汀钙片在健康人体内单、多剂量的药动学
引用本文:张维,宋颖,贾艳艳,李雪晴,陈敏纯,刘美佑,宋薇,周伦,文爱东. 匹伐他汀钙片在健康人体内单、多剂量的药动学[J]. 中国新药与临床杂志, 2013, 0(2): 135-139
作者姓名:张维  宋颖  贾艳艳  李雪晴  陈敏纯  刘美佑  宋薇  周伦  文爱东
作者单位:中国人民解放军第四军医大学第一附属医院药剂科
摘    要:目的研究匹伐他汀钙片在中国健康人体内的单、多剂量药动学。方法 30名健康志愿者随机分为3组,分别单剂量口服匹伐他汀钙片l、2、4 mg进行单剂量药动学研究,2 mg剂量组继续给药7 d,进行多剂量药动学研究。血药浓度用液相色谱-串联质谱(LC-MS/MS)法测定。结果健康受试者单剂量给药匹伐他汀钙片l、2、4 mg后,主要的药动学参数分别为tmax分别为(0.61±0.11)、(0.62±0.21)、(0.62±0.11)h,ρmax分别为(23.79±3.54)、(59.66±43.08)、(91.44±33.26) μg·L-1,AUC0-48 h分别为(59.81±12.34)、(126.8±97.90)、(216.8±34.75)μg·h·L-1,tl/2分别为(12.14±1.51)、(10.43±2.24)、(12.33±0.85)h;多剂量给药达稳态时,主要的药动学参数为tmax(0.83±0.14)h,ρmax(51.45±39.93) μg·L-1,AUCss(131.80±110.7)μg·h·L-1,t1/2(11.74±3.22)h,CL(19.92±10.54)L.h-1,ρav(5.49±4.61) μg·L-1,DF(9.43±1.21)%。结论匹伐他汀在连续多次给药后,体内无蓄积现象,血药浓度4 d已达稳态。在1~4 mg剂量范围内匹伐他汀的ρmax、AUC0-48 h和AUC0-∞均与剂量呈线性关系。

关 键 词:匹伐他汀  药动学  串联质谱法  色谱法,高压液相

Pharmacokinetics of single and multi-dose pitavastatin calcium tablets in healthy volunteers
ZHANG Wei,SONG Ying,JIA Yan-yan,LI Xue-qing,CHEN Min-chun,LIU Mei-you,SONG Wei,ZHOU Lun,WEN Ai-dong. Pharmacokinetics of single and multi-dose pitavastatin calcium tablets in healthy volunteers[J]. Chinese Journal of New Drugs and Clinical Remedies, 2013, 0(2): 135-139
Authors:ZHANG Wei  SONG Ying  JIA Yan-yan  LI Xue-qing  CHEN Min-chun  LIU Mei-you  SONG Wei  ZHOU Lun  WEN Ai-dong
Affiliation:(Department of Pharmacy,the First Affiliated Hospital of the Fourth Military Medical University of PLA,Xi’an SHAANXI 710032,China)
Abstract:AIM To study the pharmacokinetics of pitavastatin calcium tablets with a single and multipledose oral administration in Chinese healthy volunteers.METHODS Thirty healthy volunteers were randomly divided into three groups.The volunteers in three groups were administrated with single dose of pitavastatin calcium tablets 1,2,4 mg,respectively,and those who got dose of 2 mg were administrated once a day till the seventh day.Blood samples were measured by LC-MS/MS.RESULTS The main pharmacokinetic parameters of pitavastatin in volunteers who were administrated with a single dose of 1,2,4 mg were as follows: t max(0.61 ± 0.11),(0.62 ± 0.21),(0.62 ± 0.11) h,ρ max(23.79 ± 3.54),(59.66 ± 43.08),(91.44 ± 33.26) μg·L-1,AUC 0-48 h(59.81 ± 12.34),(126.80 ± 97.90),(216.80 ± 34.75) μg·h·L-1,t 1/2(12.14 ± 1.51),(10.43 ± 2.24),(12.33 ± 0.85) h,respectively.The main pharmacokinetic parameters of pitavastatin after multiple-dose administration were as follows: t max(0.83 ± 0.14) h,ρ max(51.45 ± 39.93) μg·L-1,AUC ss(131.80 ± 110.7) μg·h·L-1,t 1 /2(11.74 ± 3.22) h,CL(19.92 ± 10.54) L.h-1,ρ av(5.493 ± 4.610) μg·L-1,DF(9.43 ± 1.21) %.CONCLUSION After administration of multiple-dose pitavastatin,no accumulation occur in vivo.Plasma concentrations of pitavastatin have been in steady state till fourth day.Increase of pitavastatin dosage is positively calculated with increase of ρ max,AUC 0-∞ and AUC 0-48 h.
Keywords:pitavastatin  pharmacokinetics  tandem mass spectrometry  chromatography,high pressure liquid
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号